Cargando…
IGFBP-3 Is the Key Target of Sanguinarine in Promoting Apoptosis in Hepatocellular Carcinoma
INTRODUCTION: Chemotherapeutic treatment of hepatocellular carcinoma (HCC) has always been plagued by nonspecific and side effects. Plant extracts have potential anticancer capabilities with low cytotoxicity and few side effects, but their detailed mechanisms are still unclear, thus limiting their c...
Autores principales: | Wang, Huiwen, Wang, He, Li, Kai, Li, Shijie, Sun, Bingyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023858/ https://www.ncbi.nlm.nih.gov/pubmed/32104082 http://dx.doi.org/10.2147/CMAR.S234291 |
Ejemplares similares
-
Sanguinarine
por: Servoss, George L.
Publicado: (1910) -
SALIS transcriptionally represses IGFBP3/Caspase-7-mediated apoptosis by associating with STAT5A to promote hepatocellular carcinoma
por: Liu, Xingyuan, et al.
Publicado: (2022) -
Sanguinarine induces apoptosis in Eimeria tenella sporozoites via the generation of reactive oxygen species
por: Li, Jun-Yi, et al.
Publicado: (2022) -
Sanguinarine inhibits epithelial–mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma
por: Su, Qi, et al.
Publicado: (2019) -
Biosynthesis of Antitumoral and Bactericidal Sanguinarine
por: García, Víctor P., et al.
Publicado: (2006)